Ubiquitin/Proteasome System

The role of Th9 cells in these adverse events is not explored, but predicated on the reported ramifications of ICI therapy over the Th9 population as well as the potent anti-tumor activity triggered by these cells, maybe it’s speculated that over-activation of Th9 cells might donate to the introduction of IRAEs also

The role of Th9 cells in these adverse events is not explored, but predicated on the reported ramifications of ICI therapy over the Th9 population